Yifeng Pharmacy (603939) — Capital Reinvestment Ratio
Latest as of September 2025:
0.07x
Yifeng Pharmacy (603939) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥641.93 Million) in capital expenditures (CN¥44.81 Million). See Yifeng Pharmacy (603939) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.07x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥641.93 Million
CNY
Capital Expenditures
CN¥44.81 Million
CNY
Data as of
Sep 2025
Most recent filing
Yifeng Pharmacy Capital Reinvestment Ratio (2011–2024)
This chart tracks Yifeng Pharmacy's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Yifeng Pharmacy (2011–2024)
Year-by-year Capital Reinvestment Ratio for Yifeng Pharmacy from 2011 to 2024. For live market cap and broader valuation context, see 603939 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.16x | CN¥4.22 Billion | CN¥682.67 Million | ▲ +1.9% |
| 2023 | 0.16x | CN¥4.66 Billion | CN¥739.92 Million | ▲ +5.9% |
| 2022 | 0.15x | CN¥3.92 Billion | CN¥587.51 Million | ▼ -61.1% |
| 2021 | 0.38x | CN¥2.15 Billion | CN¥827.54 Million | ▼ -11.8% |
| 2020 | 0.44x | CN¥1.34 Billion | CN¥582.80 Million | ▼ -7.4% |
| 2019 | 0.47x | CN¥963.23 Million | CN¥454.05 Million | ▲ +3.0% |
| 2018 | 0.46x | CN¥510.71 Million | CN¥233.67 Million | ▼ -29.8% |
| 2017 | 0.65x | CN¥317.20 Million | CN¥206.73 Million | ▼ -64.2% |
| 2016 | 1.82x | CN¥139.94 Million | CN¥254.86 Million | ▲ +103.6% |
| 2015 | 0.89x | CN¥181.52 Million | CN¥162.37 Million | ▲ +97.9% |
| 2014 | 0.45x | CN¥212.35 Million | CN¥95.98 Million | ▲ +25.1% |
| 2013 | 0.36x | CN¥156.71 Million | CN¥56.61 Million | ▼ -68.4% |
| 2012 | 1.14x | CN¥80.73 Million | CN¥92.21 Million | ▲ +46.2% |
| 2011 | 0.78x | CN¥122.99 Million | CN¥96.09 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow